NCT05939804

Brief Summary

The surgical treatment of an individual with osteoarthritis and hip fracture is provided by hip replacement surgery. While restructuring the joint surfaces with surgery, it is aimed to provide both hip joint movements and to treat pain. Intense perioperative pain after hip replacement is common due to inflammatory agents and surgical intervention (eg, involvement of soft tissue and sensory nerves). Inadequately treated acute postoperative pain causes longer hospital stay, limited and delayed bed rest, decreased compliance with physical therapy, and an increased incidence of postoperative complications. It is thought that this method, which can be effective in the pain control of the patient, will be beneficial for the patient both physiologically and psychologically by reducing pain and discomfort. The most important advantage of TENS; It can be easily applied by nurses and easily taught to patients or families. The nurse has a great role in the follow-up of the patient after the surgery, as she/ he is with the patient for 24 hours. When the literature is examined, it is seen that the number of studies showing the effectiveness of TENS application in patients who underwent hip prosthesis, where studies were conducted with patients with knee gonarthrosis, is limited. In this direction, the aim of the study is to examine the effect of TENS application on patients' pain level and analgesic use in patients undergoing hip replacement.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 3, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 11, 2023

Completed
1.3 years until next milestone

Study Start

First participant enrolled

November 1, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2025

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2025

Completed
Last Updated

September 26, 2024

Status Verified

July 1, 2024

Enrollment Period

6 months

First QC Date

July 3, 2023

Last Update Submit

September 24, 2024

Conditions

Keywords

Hip ReplacementTranscutaneous Electrical Nerve StimulationPainAnalgesia

Outcome Measures

Primary Outcomes (2)

  • Change in the pain level using the VAS.

    Reducing the pain level of patients undergoing hip replacement by applying TENS. A value of 0 on the scale means that the patient does not experience pain, and a value of 10 means that he experiences pain at the most severe level

    48 hour

  • Change in analgesic consumption

    Changing analgesic consumption of patients by applying TENS. The analgesic consumption in the first 2 days after the surgery will be learned by using the questionnaire.

    48 hour

Study Arms (2)

TENS group

EXPERIMENTAL

60 minutes of TENS will be applied to the experimental group on the 0th and 1st days after the surgery, and the pain assessment at the time of movement/rest before and after the procedure will be made by the researcher. After the procedure, the amount of analgesic consumed by the experimental group in the first hour will be questioned and recorded.

Device: TENS

Control group

NO INTERVENTION

The routine treatment and care of the control group will not be interfered with.

Interventions

TENSDEVICE

TENS will be applied to the experimental group on the 0th and 1st days after the surgery, and the pain assessment at the time of movement/rest before and after the procedure will be made by the researcher.

TENS group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • be over 18 years old
  • hip replacement insertion
  • not have a pacemaker or arrhythmia
  • no history of pain, alcohol use or substance abuse
  • no history of pain, alcohol use or substance abuse
  • no history of pain, alcohol use or substance abuse
  • no history of psychiatric illness
  • no history of metastatic disease
  • being conscious, able to speak
  • No barriers to the application of TENS; no postoperative complications
  • being I, II and III in the ASA classification of the American Society of Anesthesiology, agreeing to participate in the study.

You may not qualify if:

  • having a history of epilepsy
  • Using analgesics at least 1 hour before TENS is applied
  • the presence of a wound in the area where the electrode will be placed.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cukurova University

Adana, Adana, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Hip FracturesPain, PostoperativeAgnosiaPain

Interventions

Transcutaneous Electric Nerve Stimulation

Condition Hierarchy (Ancestors)

Femoral FracturesFractures, BoneWounds and InjuriesHip InjuriesLeg InjuriesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsNeurologic ManifestationsSigns and SymptomsPerceptual DisordersNeurobehavioral ManifestationsNervous System Diseases

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsPhysical Therapy ModalitiesRehabilitationAnalgesiaAnesthesia and Analgesia

Study Officials

  • Açelya Türkmen, PhD

    Cukurova University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Açelya Türkmen, PhD

CONTACT

Sevilay Erden, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 3, 2023

First Posted

July 11, 2023

Study Start

November 1, 2024

Primary Completion

May 1, 2025

Study Completion

September 1, 2025

Last Updated

September 26, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Locations